Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN-BLMF vs BELINOSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN-BLMF vs BELINOSTAT: Safety Overview

Metric BELANTAMAB MAFODOTIN-BLMF BELINOSTAT
Total FAERS Reports 150 305
Deaths Reported 60 103
Death Rate 40.0% 33.8%
Hospitalizations 36 123
Average Patient Age 65.9 yrs 62.0 yrs
% Female Patients 48.3% 40.4%
FDA Approval Date N/A Jul 3, 2014
Manufacturer N/A Acrotech Biopharma Inc
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription